Germline pathogenic mutations of MLH1, MSH2, MSH6 and PMS2 cause the Lynch syndrome, the most common type of hereditary cancer syndrome affecting 1 in 280–400 individuals [3]. Here, MSH2 is linked to Lynch syndrome.